Zonisamide Patent Expiration
Zonisamide is Used for controlling seizures. It was first introduced by Concordia Pharmaceuticals Inc
Zonisamide Patents
Given below is the list of patents protecting Zonisamide, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Zonisade | US11478456 | Oral pharmaceutical composition comprising Zonisamide and process of preparation thereof | Aug 18, 2038 | Azurity |
Zonisade | US11529333 | Oral pharmaceutical composition comprising zonisamide and process of preparation thereof | Aug 18, 2038 | Azurity |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Zonisamide's patents.
Latest Legal Activities on Zonisamide's Patents
Given below is the list recent legal activities going on the following patents of Zonisamide.
Activity | Date | Patent Number |
---|---|---|
Recordation of Patent Grant Mailed Critical | 20 Dec, 2022 | US11529333 |
Patent Issue Date Used in PTA Calculation Critical | 20 Dec, 2022 | US11529333 |
Email Notification Critical | 01 Dec, 2022 | US11529333 |
Issue Notification Mailed Critical | 30 Nov, 2022 | US11529333 |
Application Is Considered Ready for Issue Critical | 23 Nov, 2022 | US11529333 |
Dispatch to FDC | 23 Nov, 2022 | US11529333 |
Issue Fee Payment Verified Critical | 02 Nov, 2022 | US11529333 |
Issue Fee Payment Received Critical | 02 Nov, 2022 | US11529333 |
Recordation of Patent Grant Mailed Critical | 25 Oct, 2022 | US11478456 |
Patent Issue Date Used in PTA Calculation Critical | 25 Oct, 2022 | US11478456 |
Zonisamide's Family Patents
Explore Our Curated Drug Screens
Zonisamide Generic API Manufacturers
Several generic applications have been filed for Zonisamide. The first generic version for Zonisamide was by Roxane Laboratories Inc and was approved on Dec 22, 2005. And the latest generic version is by Unichem Laboratories Ltd and was approved on Jan 26, 2021.
Given below is the list of companies who have filed for Zonisamide generic, along with the locations of their manufacturing plants worldwide.
1. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Ani Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
50MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
100MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
2. APOTEX INC
Apotex Inc Etobicoke Site has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Apotex Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | capsule | Prescription | ORAL | AB | Dec 22, 2005 |
50MG | capsule | Prescription | ORAL | AB | Dec 22, 2005 |
100MG | capsule | Prescription | ORAL | AB | Dec 22, 2005 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
Country | City | Firm Name | ||||||
---|---|---|---|---|---|---|---|---|
Canada |
|
3. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Prescription | ORAL | AB | Dec 22, 2005 |
50MG | capsule | Prescription | ORAL | AB | Sep 29, 2006 |
25MG | capsule | Prescription | ORAL | AB | Sep 29, 2006 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
4. BIONPHARMA
Bionpharma Inc has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Bionpharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | capsule | Prescription | ORAL | AB | Aug 16, 2006 |
100MG | capsule | Prescription | ORAL | AB | Aug 16, 2006 |
50MG | capsule | Prescription | ORAL | AB | Aug 16, 2006 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
5. EPIC PHARMA LLC
Epic Pharma Llc has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Discontinued | ORAL | N/A | Feb 21, 2007 |
25MG | capsule | Discontinued | ORAL | N/A | Feb 21, 2007 |
50MG | capsule | Discontinued | ORAL | N/A | Feb 21, 2007 |
6. GLENMARK PHARMS INC
Glenmark Pharmaceuticals Inc Usa has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | capsule | Prescription | ORAL | AB | Jan 30, 2006 |
50MG | capsule | Prescription | ORAL | AB | Jan 30, 2006 |
100MG | capsule | Prescription | ORAL | AB | Jan 30, 2006 |
7. GRANULES
Granules India Ltd has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Granules.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Prescription | ORAL | AB | Dec 22, 2005 |
25MG | capsule | Prescription | ORAL | AB | Jul 27, 2006 |
50MG | capsule | Prescription | ORAL | AB | Jul 27, 2006 |
Manufacturing Plant Locations New
Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.
Country | City | Firm Name | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||
India |
|
8. HERITAGE PHARMA AVET
Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Heritage Pharma Avet.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG | capsule | Discontinued | ORAL | N/A | Apr 20, 2006 |
25MG | capsule | Discontinued | ORAL | N/A | Apr 20, 2006 |
100MG | capsule | Discontinued | ORAL | N/A | Apr 20, 2006 |
9. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Prescription | ORAL | AB | May 31, 2006 |
25MG | capsule | Prescription | ORAL | AB | May 31, 2006 |
50MG | capsule | Prescription | ORAL | AB | May 31, 2006 |
10. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
50MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
100MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
11. RISING
Rising Pharma Holding Inc has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
50MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
100MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||
Mexico |
| |||||||||||||||||||
India |
|
12. ROXANE
Roxane Laboratories Inc has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Roxane.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
100MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
50MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
13. SUN PHARM INDS (IN)
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds (in).
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG | capsule | Prescription | ORAL | AB | Mar 17, 2006 |
25MG | capsule | Prescription | ORAL | AB | Mar 17, 2006 |
100MG | capsule | Prescription | ORAL | AB | Mar 17, 2006 |
14. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
50MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
100MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
15. UNICHEM
Unichem Laboratories Ltd has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Unichem.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | capsule | Prescription | ORAL | AB | Jan 26, 2021 |
50MG | capsule | Prescription | ORAL | AB | Jan 26, 2021 |
100MG | capsule | Prescription | ORAL | AB | Jan 26, 2021 |
Manufacturing Plant Locations New
Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.
Country | City | Firm Name | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||||||
United States |
|
16. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
25MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
50MG | capsule | Discontinued | ORAL | N/A | Dec 22, 2005 |
17. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 3 different strengths of generic version for Zonisamide. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG | capsule | Prescription | ORAL | AB | Oct 16, 2006 |
100MG | capsule | Prescription | ORAL | AB | Oct 16, 2006 |
25MG | capsule | Prescription | ORAL | AB | Oct 16, 2006 |
Manufacturing Plant Locations New
Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|